Literature DB >> 11223823

Clinicopathologic study of mixed hepatocellular and cholangiocellular carcinoma: modes of spreading and choice of surgical treatment by reference to macroscopic type.

A Sasaki1, K Kawano, M Aramaki, T Ohno, K Tahara, Y Takeuchi, T Yoshida, S Kitano.   

Abstract

BACKGROUND AND OBJECTIVES: Clinicopathologic features and the choice of surgical treatment for mixed hepatocellular and cholangiocellular carcinoma (MHC) remain controversial.
METHODS: We evaluated the clinicopathological features of seven cases of MHC (one autopsied and six surgically resected cases). MHCs were divided into two classes by reference to macroscopic appearance: four were of the single nodular (SN) type and three were of the multinodular (MN) type.
RESULTS: The mean age of patients and mean preoperative level of serum alpha-fetoprotein were 44.5 years and 56,457 ng/ml for the SN type and 63.7 years and 1,227 ng/ml for the MN type, respectively. Histologically, invasion of the portal vein, the hepatic vein, and the perineural space was found in three, two, and zero cases of SN type tumors and in three, three, and one cases of MN type tumors, respectively. Lymph node metastases were found only in two patients with MN type MHC.
CONCLUSIONS: MHC of the SN type had a pattern of infiltration similar to hepatocellular carcinoma. By contrast, MHC of the MN type resembled intrahepatic cholangiocellular carcinoma. It is suggested that lymphadenectomy might be necessary for treatment of selected MHC, in particular MHC with a multinodular appearance.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11223823     DOI: 10.1002/1096-9098(200101)76:1<37::aid-jso1007>3.0.co;2-0

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  10 in total

Review 1.  Combined hepatocellular and cholangiocarcinoma associated with hepatolithiasis: report of a case.

Authors:  Kemal Deniz; Edip Torun; Mehmet Celikbilek; Erdoğan Sözüer
Journal:  Surg Today       Date:  2011-03-23       Impact factor: 2.549

2.  Clinical and pathological features of Allen's type C classification of resected combined hepatocellular and cholangiocarcinoma: a comparative study with hepatocellular carcinoma and cholangiocellular carcinoma.

Authors:  Di Tang; Hiroaki Nagano; Masato Nakamura; Hiroshi Wada; Shigeru Marubashi; Atsushi Miyamoto; Yutaka Takeda; Koji Umeshita; Keizo Dono; Morito Monden
Journal:  J Gastrointest Surg       Date:  2006 Jul-Aug       Impact factor: 3.452

Review 3.  Surgical Treatment of Hepatocholangiocarcinoma: A Systematic Review.

Authors:  Damiano Gentile; Matteo Donadon; Ana Lleo; Alessio Aghemo; Massimo Roncalli; Luca di Tommaso; Guido Torzilli
Journal:  Liver Cancer       Date:  2019-11-01       Impact factor: 11.740

4.  Combined hepatocellular and cholangiocellular carcinoma presenting with radiological characteristics of focal nodular hyperplasia.

Authors:  Inneke Willekens; Anne Hoorens; Caroline Geers; Bart Op de Beeck; Frederik Vandenbroucke; Johan de Mey
Journal:  World J Gastroenterol       Date:  2009-08-21       Impact factor: 5.742

5.  Primary hepatic cancers with multiple pathologic features in a patient with hepatitis C: report of a case.

Authors:  Go Oshima; Masahiro Shinoda; Minoru Tanabe; Yohei Masugi; Akihisa Ueno; Kiminori Takano; Minoru Kitago; Osamu Itano; Shigeyuki Kawachi; Kentaro Ohara; Masaya Oda; Akihiro Tanimoto; Michiie Sakamaoto; Yuko Kitagawa
Journal:  Int Surg       Date:  2012 Jan-Mar

6.  An update on long-term outcome of curative hepatic resection for hepatocholangiocarcinoma.

Authors:  Kenneth Siu-Ho Chok; Kelvin K C Ng; Tan To Cheung; Wai Key Yuen; Ronnie T P Poon; Chung Mau Lo; Sheung Tat Fan
Journal:  World J Surg       Date:  2009-09       Impact factor: 3.352

7.  Molecular diagnosis of primary liver cancer by microsatellite DNA analysis in the serum.

Authors:  Y-C Chang; C-L Ho; Helen H-W Chen; T-T Chang; W-W Lai; Y-C Dai; W-Y Lee; N-H Chow
Journal:  Br J Cancer       Date:  2002-12-02       Impact factor: 7.640

Review 8.  Combined Hepatocellular-Cholangiocarcinoma: What the Multidisciplinary Team Should Know.

Authors:  Carmen Cutolo; Federica Dell'Aversana; Roberta Fusco; Giulia Grazzini; Giuditta Chiti; Igino Simonetti; Federico Bruno; Pierpaolo Palumbo; Luca Pierpaoli; Tommaso Valeri; Francesco Izzo; Andrea Giovagnoni; Roberto Grassi; Vittorio Miele; Antonio Barile; Vincenza Granata
Journal:  Diagnostics (Basel)       Date:  2022-04-02

9.  A case report of synchronous double primary liver cancers combined with early gastric cancer.

Authors:  Jae Young Chang; Byung-Ho Kim; Sung Wha Hong; Youn Wha Kim; Joo Hyeong Oh
Journal:  Korean J Intern Med       Date:  2003-06       Impact factor: 2.884

Review 10.  Treatment of Combined Hepatocellular and Cholangiocarcinoma.

Authors:  Simona Leoni; Vito Sansone; Stefania De Lorenzo; Luca Ielasi; Francesco Tovoli; Matteo Renzulli; Rita Golfieri; Daniele Spinelli; Fabio Piscaglia
Journal:  Cancers (Basel)       Date:  2020-03-26       Impact factor: 6.639

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.